EiceDRIVER™ SIL/Boost - Next generation EiceDRIVER™ for hybrid and electric vehicle applications

Product Brief
EiceDRIVER™ SIL/Boost
Next generation EiceDRIVER™ for hybrid and electric vehicle applications
Key Features
The 1EDI2001AS is a high-voltage IGBT gate driver designed for automotive motor
drives above 10kW. It’s based on Infineon’s Coreless Transformer (CLT) technology,
„„
On-chip galvanic isolation
providing galvanic insulation between low voltage and high voltage domains.
„„
Supports active short circuit for
A large spectrum of safety-related functions has been implemented in order to support
functional safety requirements at system level. On the high voltage side (“secondary”
side) the 1EDI2001AS is dimensioned to drive an external booster stage.
ASIL C/D system certification
„„
Standard SPI interface for control
and diagnosis
„„
Over-current monitoring
The 1EBN1001AE is based on high performance bipolar technology and replaces
buffer stages based on discrete devices. Because of its thermally optimized exposed
(DESAT, OCP)
„„
AEC Q100 Qualified
pad package, the 1EBN1001AEs is able to drive and sink peak currents up to 15 A.
This makes this device suitable for most inverter systems in automotive applications.
Key Benefits
„„
Offers potential for a cost
The 1EDI2001AS and the 1EBN1001AE can be used optimally together with the
effective implementation of ASIL
Infineon HybridPack™ IGBT Modules to implement an optimized system for electric
C/D on system level
and hybrid vehicles.
„„
The chip-set saves significant
PCB area
Application
„„
Main inverter for Electric and Hybrid vehicles
www.infineon.com/automotive-eicedriver
Product Brief
EiceDRIVER™ SIL/Boost
Next generation EiceDRIVER™ for hybrid and electric vehicle applications
1EDI2001AS/1EBN1001AE Application Example
+5V
VCC1
+15V
VCC2
Rpu1
Cd
NFLTA
DESAT
Rpu1
NFLTB
C1
REF0
C1
R1
REF0
C1
LV Logic
C1
R1
GND1
C1
RS1
GND1
INP
TON
C1
GND1
C1
GND1
Rref1
GND1
TONI
RDACLP
Rref2
SDI
SCLK
NCS
OSD
Cosd
NUV2
VCC1
ASC
R2
VEE2
VEE2
Rocp
TOFFO
Cd
GND2
VCC2
Lsense(*)
OCP
Dgcl2(*)
Rsense
VEE2
OCPG
Cd
VREG
VEE2
Rgoff
Dgcl1(*)
GND2
GATE
GND2
GND1
EiceDRIVER™
Boost
C2
Cocp
Cref1
Rgon
0 Vector
Generation
Rpu2
GND2
VEE2
TONO
GND2
Cref2
Rosd
Dtvsacl Dacl
Racl2
DACLP
GND2
NRST/RDY
Dacl2
Racl2
ACLI
C2DACLP
IREF2
REF0
VCC2
TOFFI
DACLP
IREF1
Cd
GND2
INSTP
EN
VCC2
GND2
GND2
EiceDRIVER™
TOFF
SIL
SDO
R1
R1
Cd
DEBUG
Rpu1
R1
Ddesat
Cdesat
R1
R1
VCC2
Rdesat
Cvreg
GND2
Dgcl3(*)
-8V
Additional product offerings for Hybrid Electric & Electric Vehicle Solutions can be found at:
www.infineon.com/automotive-eicedriver
Published by
Infineon Technologies AG
85579 Neubiberg, Germany
© 2013 Infineon Technologies AG.
All Rights Reserved.
Visit us:
www.infineon.com
Order Number: B134-H9806-X-X-7600
Date: 05 / 2013
Attention please!
The information given in this document shall in no event
be regarded as a guarantee of conditions or characteristics
(“Beschaffenheitsgarantie”). With respect to any examples
or hints given herein, any typical values stated herein and/
or any information regarding the application of the device,
Infineon Technologies hereby disclaims any and all warranties and liabilities of any kind, including without limitation warranties of non-infringement of intellectual property
rights of any third party.
Information
For further information on technology, delivery terms and
conditions and prices please contact your nearest Infineon
Technologies Office (www.infineon.com).
Warnings
Due to technical requirements components may contain
dangerous substances. For information on the types in
question please contact your nearest Infineon Technologies
Office. Infineon Technologies Components may only be
used in life-support devices or systems with the express
written approval of Infineon Technologies, if a failure of
such components can reasonably be expected to cause
the failure of that life-support device or system, or to affect
the safety or effectiveness of that device or system. Life
support devices or systems are intended to be implanted
in the human body, or to support and/or maintain and
sustain and/or protect human life. If they fail, it is reasonable to assume that the health of the user or other persons
may be endangered.